Just like a game of chess, sometimes you only have one option to escape defeat and live to fight another day. Apparently, Elite now has the financing to start clinical trials by the end of this year. It could be a checkmate once clinical trials have been successfully completed with the FDA-approval. This would sure open the doors for Elite to more deals coming their way and to dictate the terms of any deals. Cheers!
Market Data 
Markets 
